Literature DB >> 20159907

Employment status and socio-economic burden in systemic sclerosis: a cross-sectional survey.

Christelle Nguyen1, Serge Poiraudeau, Caroline Mestre-Stanislas, François Rannou, Alice Bérezné, Agathe Papelard, Dominique Choudat, Michel Revel, Loïc Guillevin, Luc Mouthon.   

Abstract

OBJECTIVE: To assess employment status and socio-economic burden in SSc patients.
METHODS: Eighty-seven SSc patients (72 females), fulfilling the ACR or the Leroy and Medsger criteria, or both, were evaluated for employment status, socio-economic burden and handicap. Statistical analysis involved Mann-Whitney U-test and Fisher's exact test and backward stepwise regression analysis.
RESULTS: In total, 60.9% of the SSc patients were on full-time sick leave and 35.6% were receiving a disability pension. On univariate analysis, myalgia was the only clinical manifestation more frequently encountered in sick-leave patients than others (73.6 vs 47.1%; P = 0.012). Karnofsky performance status (KPS) was lower in SSc patients who were on sick leave or were receiving a disability pension than others [78.5 (10.6) vs 85.8 (9.0); P = 0.004 and 78.1 (8.7) vs 83.1 (11.2); P = 0.016, respectively]. In addition, greater global, hand and mouth handicaps and depression were observed in patients on sick leave [HAQ 0.9 (0.7) vs 0.6 (0.5); P = 0.021; Cochin Hand Function Scale 21.7 (18.9) vs 10.7 (12.1); P = 0.003; mouth handicap scale 20.2 (10.8) vs 14.6 (10.0); P = 0.014; and depression dimension of the hospital anxiety and depression scale 7.1 (3.9) vs 4.8 (3.4); P = 0.003]. On multivariate analysis, factors associated with sick leave were KPS [odds ratio (OR) 0.92; 95%CI 0.88, 0.98] and myalgias (OR 3.19; 95% CI 1.19, 8.58), and the factor associated with receiving a disability pension was decreased income (OR 8.19; 95% CI 2.67, 25.12).
CONCLUSIONS: SSc patients commonly have to take full-time sick leave from work. Despite such patients receiving disability pensions, the socio-economic burden is considerable.

Entities:  

Mesh:

Year:  2010        PMID: 20159907     DOI: 10.1093/rheumatology/kep400

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  6 in total

1.  Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort.

Authors:  Roozbeh Sharif; Maureen D Mayes; Perry M Nicassio; Emilio B Gonzalez; Hilda Draeger; Terry A McNearney; Rosa M Estrada-Y-Martin; Deepthi K Nair; John D Reveille; Frank C Arnett; Shervin Assassi
Journal:  Semin Arthritis Rheum       Date:  2011-03-22       Impact factor: 5.532

Review 2.  Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.

Authors:  Natalie McCormick; Carlo A Marra; J Antonio Aviña-Zubieta
Journal:  Curr Rheumatol Rep       Date:  2017-10-30       Impact factor: 4.592

3.  Drug compliance in patients with systemic scleroderma.

Authors:  Lucie Hromadkova; Tomas Soukup; Eva Cermakova; Jiri Vlcek
Journal:  Clin Rheumatol       Date:  2012-08-09       Impact factor: 2.980

4.  Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis.

Authors:  Christelle Nguyen; Alice Bérezné; Thierry Baubet; Caroline Mestre-Stanislas; François Rannou; Agathe Papelard; Sandrine Morell-Dubois; Michel Revel; Loïc Guillevin; Serge Poiraudeau; Luc Mouthon
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

5.  Work Productivity and Economic Burden of Systemic Sclerosis in a Multiethnic Asian Population.

Authors:  Ling Xiang; Sandra M Y Kua; Andrea H L Low
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-03-12       Impact factor: 5.178

6.  Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey.

Authors:  Christelle Nguyen; Brigitte Ranque; Thierry Baubet; Alice Bérezné; Caroline Mestre-Stanislas; François Rannou; Agathe Papelard; Sandrine Morell-Dubois; Michel Revel; Marie-Rose Moro; Loïc Guillevin; Serge Poiraudeau; Luc Mouthon
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.